Amyloid-related imaging abnormalities

Disease2 papers1 finding

Human trial1

Associations

1

Frailty

upin humans1

1 study

Frailty raises the risk of amyloid-related imaging abnormalities in humans.
Reviewearly Alzheimer's disease under anti-amyloid therapy
Beyond Amyloid: Systemic and Brain Frailty as Determinants of Response to Anti-Amyloid Therapy in Alzheimer's Disease-A Conceptual Review · Medicina (Kaunas, Lithuania) · 2 Aug 2026

Funding

National Institute on AgingUS$204.9k2 grants since 2025

Defining Multimodal White Matter Injury Markers for Cerebral Amyloid Angiopathy (CAA) and Amyloid-related Imaging Abnormalities (ARIA)
National Institute on AgingMassachusetts General HospitalUS$129.3k2026–2031
Cerebral blood flow resistance mapping to identify amyloid-related imaging abnormality (ARIA) risk in Alzheimer's disease
National Institute on AgingVanderbilt University Medical CenterUS$75.5k2025–2027

Latest

4

Alzheimer's & DementiaIn silico9 Sep

MCH-Guard: Multimodal machine learning framework for risk stratification of cerebral microhemorrhage risk in the Alzheimer's Disease Neuroimaging Initiative

Alzheimer's & DementiaHuman trial27 Aug

Dynamic imaging markers of incident microhemorrhages and superficial siderosis in the A4 study: A longitudinal person-interval analysis

MedicinaReview27 Aug

Beyond Amyloid: Systemic and Brain Frailty as Determinants of Response to Anti-Amyloid Therapy in Alzheimer's Disease-A Conceptual Review

Alzheimer's disease

GSA 2025 AbstractReview3 Jan

Risk Factors and Management Strategies for Cerebral Amyloid Angiopathy